Surgical Innovations and Outcomes in the Management of Rectal Cancer: A Departmental Study on Advanced Techniques and Postoperative Care
Keywords:
Rectal cancer, Minimally invasive Surgery, taTME, ERAS protocolsAbstract
Background: Rectal cancer is a significant global health issue, accounting for a substantial proportion of colorectal cancer cases. Surgical innovations and comprehensive postoperative care have significantly improved patient outcomes. This study evaluates the impact of advanced surgical techniques and Enhanced Recovery After Surgery (ERAS) protocols on managing rectal cancer across multiple centers in the Rajshahi Division. Objective: The study aimed to assess the effectiveness of minimally invasive surgical techniques, including laparoscopic, -assisted, and transanal total mesorectal excision (taTME), compared to traditional open Surgery. It also examined the role of ERAS protocols in enhancing recovery and reducing complications. Method: This multicenter, retrospective study included 88 patients diagnosed with rectal cancer who underwent surgical treatment from June 2021 to June 2023 across various hospitals in the Rajshahi Division. Patients were categorized based on the type of Surgery received, and postoperative outcomes, including complications, hospital stay, and survival rates, were analyzed. Data were statistically evaluated using SPSS version 26, with significance at p < 0.05. Result: Of the 88 patients, 50% underwent laparoscopic Surgery, 20% -assisted surgery, 10% taTME, and 20% open surgery. Patients who underwent minimally invasive techniques had significantly shorter hospital stays (mean of 6 days) than open Surgery (mean of 10 days, p = 0.001). The overall complication rate was lower in the minimally invasive group (17%) compared to the open surgery group (30%). Two-year survival rates were highest in the -assisted and taTME groups (90% and 92%, respectively). Conclusions: Advanced surgical techniques, particularly -assisted Surgery, and taTME, combined with ERAS protocols, significantly improve patient outcomes in rectal cancer management.
References
1. Keller, D. S., Berho, M., Perez, R. O., Wexner, S. D., & Chand, M. (2020). The multidisciplinary management of rectal cancer. Nature Reviews Gastroenterology & Hepatology, 17(7), 414-429.
2. Bravo, L. E., García, L. S., Collazos, P., Carrascal, E., Ardila, E. K. G., Millan, E., & Holguín, J. (2022). Cancer epidemiology in Cali, 60 years of experience. Colombia Médica, 53(1).
3. Peacock, O., Waters, P. S., Bressel, M., Lynch, A. C., Wakeman, C., Eglinton, T., ... & Heriot, A. G. (2019). Prognostic factors and patterns of failure after Surgery for T4 rectal cancer in the beyond total mesorectal excision era. Journal of British Surgery, 106(12), 1685-1696.
4. Jiang, W. Z., Xu, J. M., Xing, J. D., Qiu, H. Z., Wang, Z. Q., Kang, L., ... & LASRE trial investigators. (2022). Short-term outcomes of laparoscopy-assisted vs open Surgery for patients with low rectal cancer: the LASRE randomized clinical trial. JAMA oncology, 8(11), 1607-1615.
5. Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. (2019). Korean practice guideline for gastric cancer 2018: an evidence-based, multidisciplinary approach. Journal of gastric cancer, 19(1), 1-48.
6. Jahansouz, C., Arsoniadis, E. G., & Sands, D. R. (2021). Conventional and transanal minimally invasive Surgery for rectal neoplasia. Mini-invasive Surgery, 5, 1.
7. Penna, M., Hompes, R., Arnold, S., Wynn, G., Austin, R., Warusavitarne, J., ... & Tekkis, P. P. (2019). Incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal excision: results from the international TaTME registry. Annals of Surgery, 269(4), 700-711.
8. Gustafsson, U. O., Scott, M. J., Hubner, M., Nygren, J., Demartines, N., Francis, N., ... & Ljungqvist, O. (2019). Guidelines for perioperative care in elective colorectal Surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations: 2018. World journal of Surgery, 43, 659-695.
9. Ma, B., Ren, Y., Chen, Y., Lian, B., Jiang, P., Li, Y., ... & Meng, Q. (2019). Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical Surgery? A systematic review and meta-analysis. International Journal of Colorectal Disease, 34, 113-121.
10. PelvEx Collaborative. (2022). Contemporary management of locally advanced and recurrent rectal cancer: views from the PelvEx Collaborative. Cancers, 14(5), 1161.
11. Biswas, B., Chowdhury, A. S., Akter, S., Fatema, K., Reem, C. S. A., Tuhin, E., & Hasan, H. (2024). Knowledge and attitude about COVID-19 and importance of diet: A cross-sectional study among Bangladeshi people. Bangladesh Journal of Food and Nutrition, 1(1), 04-12.
12. Aktar, S., Akter, K., Akther, K., Begum, S., Islam, T., & Hasan, H. (2022). Knowledge Regarding the Prevention of Cervical Cancer of Adolescent Girls at Rajshahi Division.
13. Kim, T. H., Kim, I. H., Kang, S. J., Choi, M., Kim, B. H., Eom, B. W., ... & Kong, S. H. (2023). Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. Journal of gastric cancer, 23(1), 3.
